BE1000783A3 - Derives du 1,3-dioxolanne et du 1,3-dioxanne et leur utilisation comme medicaments. - Google Patents

Derives du 1,3-dioxolanne et du 1,3-dioxanne et leur utilisation comme medicaments. Download PDF

Info

Publication number
BE1000783A3
BE1000783A3 BE8800360A BE8800360A BE1000783A3 BE 1000783 A3 BE1000783 A3 BE 1000783A3 BE 8800360 A BE8800360 A BE 8800360A BE 8800360 A BE8800360 A BE 8800360A BE 1000783 A3 BE1000783 A3 BE 1000783A3
Authority
BE
Belgium
Prior art keywords
sep
tolyl
formula
compound
signifies
Prior art date
Application number
BE8800360A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1000783A3 publication Critical patent/BE1000783A3/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicinal Preparation (AREA)
BE8800360A 1987-04-01 1988-03-28 Derives du 1,3-dioxolanne et du 1,3-dioxanne et leur utilisation comme medicaments. BE1000783A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3411887A 1987-04-01 1987-04-01

Publications (1)

Publication Number Publication Date
BE1000783A3 true BE1000783A3 (fr) 1989-04-04

Family

ID=21874422

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8800360A BE1000783A3 (fr) 1987-04-01 1988-03-28 Derives du 1,3-dioxolanne et du 1,3-dioxanne et leur utilisation comme medicaments.

Country Status (18)

Country Link
JP (1) JPS63277672A (es)
KR (1) KR880012224A (es)
AU (1) AU1400788A (es)
BE (1) BE1000783A3 (es)
DE (1) DE3810874A1 (es)
DK (1) DK179288A (es)
ES (1) ES2011831A6 (es)
FR (1) FR2613226B1 (es)
GB (1) GB2202849A (es)
GR (1) GR880100196A (es)
HU (1) HUT50156A (es)
IL (1) IL85920A0 (es)
IT (1) IT1219895B (es)
LU (1) LU87176A1 (es)
NL (1) NL8800805A (es)
PT (1) PT87127B (es)
SE (1) SE8801166L (es)
ZA (1) ZA882350B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701961D0 (en) * 1987-01-29 1987-03-04 Unilever Plc Perfumery materials

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104572A1 (de) * 1982-09-25 1984-04-04 Hoechst Aktiengesellschaft Benzylether von Phenol-Mannich-Basen, Verfahren zu ihrer Herstellung, ihre Verwendung sowie pharmazeutische Präparate auf Basis dieser Verbindungen, Zwischenprodukte und Verfahren zu deren Herstellung

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104572A1 (de) * 1982-09-25 1984-04-04 Hoechst Aktiengesellschaft Benzylether von Phenol-Mannich-Basen, Verfahren zu ihrer Herstellung, ihre Verwendung sowie pharmazeutische Präparate auf Basis dieser Verbindungen, Zwischenprodukte und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
IT8847797A0 (it) 1988-03-30
FR2613226A1 (fr) 1988-10-07
GR880100196A (el) 1989-01-31
AU1400788A (en) 1988-10-06
SE8801166L (sv) 1988-10-02
DK179288D0 (da) 1988-03-30
LU87176A1 (fr) 1988-11-17
IT1219895B (it) 1990-05-24
SE8801166D0 (sv) 1988-03-29
PT87127A (pt) 1988-04-01
DE3810874A1 (de) 1988-10-20
FR2613226B1 (fr) 1989-09-15
ES2011831A6 (es) 1990-02-16
HUT50156A (en) 1989-12-28
KR880012224A (ko) 1988-11-26
PT87127B (pt) 1992-07-31
DK179288A (da) 1988-10-02
IL85920A0 (en) 1988-09-30
ZA882350B (en) 1989-12-27
NL8800805A (nl) 1988-11-01
GB8807503D0 (en) 1988-05-05
GB2202849A (en) 1988-10-05
JPS63277672A (ja) 1988-11-15

Similar Documents

Publication Publication Date Title
CA1197247A (fr) Procede pour la preparation de nouveaux derives d'imidazotetrazinones et les derives ainsi obtenus
CH643546A5 (fr) Procede pour la preparation de derives d'hydantoine.
FR2498188A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
EP0109866B1 (fr) Nouveaux dérivés de la sulfonylurée, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
EP0576619B1 (fr) Compositions therapeutiques a base de derives de 1,2-dithiole-3-thione
CH635832A5 (fr) Derives du tetrazole et composition pharmaceutique les contenant.
BE1003632A3 (fr) Nouveaux derives de l'adenosine, leur preparation et leur utilisation comme medicaments.
BE1000783A3 (fr) Derives du 1,3-dioxolanne et du 1,3-dioxanne et leur utilisation comme medicaments.
FR2492378A1 (fr) Derives de type 6h-dibenzo(b,d) pyranne 6-substitues utiles notamment comme medicaments antiulcereux, immunomodulateurs et antiviraux et procedes de leur preparation
FR2550091A1 (fr) Composition pharmaceutique ou veterinaire destinee a combattre des troubles ischemiques cardiaques contenant un derive du benzofuranne
EP0017578B1 (fr) Acides 5-(2-hydroxy-3-thiopropoxy)chromone-2-carboxyliques, leurs sels et esters, procédé de préparation et médicaments
EP0126013B1 (fr) Dithiodiacétamides cycliques, procédé pour leur préparation et compositions pharmaceutiques en contenant
BE897156A (fr) Derives du dithioiane, leur preparation et leur utilisation
EP0179076B1 (fr) Derives sulfures de l'hydantoine et compositions pharmaceutiques les contenant
EP0151052B1 (fr) Aminoéthylimidazole, composition pharmaceutique en contenant et procédé de préparation
FR2605006A1 (fr) Derives du 5-fluorouracile, procede pour leur preparation, composition anticancereuse les contenant et leur utilisation pour la preparation d'une composition destinee au traitement d'un cancer
BE876625R (fr) Derives d'imidazole-4-carboxamide 5-0-acyles, procede pour leur preparation et medicaments en contenant
LU85348A1 (fr) Nouveaux derives d'acylaminophenols,leur preparation et leur utilisation comme medicaments
EP0027085B1 (fr) Nouveaux dérivés de la thiazolo (3,2-c) benzoxazine-1,3, leur préparation et les médicaments qui les contiennent
CH647503A5 (fr) Derives de la 16-methoxy-16-methyl-prostaglandine e(1), procede pour leur synthese et medicaments gastro-protecteurs contenant lesdits derives.
FR2573422A1 (fr) Nouveaux analogues de prostaglandines, leur preparation et les compositions pharmaceutiques qui les contiennent
WO1995029154A1 (fr) Nouveaux derives de benzylamines, leur procede de fabrication et les compositions pharmaceutiques les renfermant
FR2495615A1 (fr) Ethers d'hydroxymethylpyrazines substituees, leur preparation et leur utilisation therapeutique en tant qu'agents antilipolytiques, hypotriglyceridemiques et hypocholesterolemiques
FR2528843A2 (fr) Nouveaux derives du dithiole-1,2 ylidene-3 ammonium, leur preparation et les medicaments qui les contiennent
EP0275221A2 (fr) Nouveaux dérivés du N-(1H-indol 4-yl) benzamide ainsi que leurs sels, leur application à titre de médicaments et les compositions les renfermant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: S.A. SANDOZ

Effective date: 19910331